Cancer Institute A national cancer institute
designated cancer center

James L. Zehnder, M.D.

Publication Details

  • An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.

    Wrone EM, Zehnder JL, Hornberger JM, McCann LM, Coplon NS, Fortmann SP. Kidney Int. 2001; 60 (3): 1106-13

    It is unclear whether total serum homocysteine (tHcy) and the C677T mutation of methylenetetrahydrofolate reductase (MTHFR) are associated with cardiovascular disease (CVD) in patients with end-stage renal disease (ESRD).

    PubMedID: 11532106

Stanford Medicine Resources:

Footer Links: